WuXi Biologics (Cayman), Inc. (WXXWY)
11.73
+0.20
(+1.73%)
USD |
OTCM |
Oct 28, 16:00
WuXi Biologics Max Drawdown (5Y) : 94.03% for Sept. 30, 2026
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| September 30, 2026 | 94.03% |
| August 31, 2026 | 94.03% |
| July 31, 2026 | 94.03% |
| June 30, 2026 | 94.03% |
| May 31, 2026 | 94.03% |
| April 30, 2026 | 94.03% |
| March 31, 2026 | 94.03% |
| February 28, 2026 | 94.03% |
| January 31, 2026 | 94.03% |
| December 31, 2025 | 94.03% |
| November 30, 2025 | 94.03% |
| October 31, 2025 | 94.03% |
| September 30, 2025 | 94.03% |
| August 31, 2025 | 94.03% |
| July 31, 2025 | 94.03% |
| June 30, 2025 | 94.03% |
| May 31, 2025 | 94.03% |
| April 30, 2025 | 94.03% |
| March 31, 2025 | 94.03% |
| February 28, 2025 | 94.03% |
| January 31, 2025 | 94.03% |
| December 31, 2024 | 94.03% |
| November 30, 2024 | 94.03% |
| October 31, 2024 | 94.03% |
| September 30, 2024 | 94.03% |
| Date | Value |
|---|---|
| August 31, 2024 | 94.03% |
| July 31, 2024 | 93.91% |
| June 30, 2024 | 93.66% |
| May 31, 2024 | 93.45% |
| April 30, 2024 | 92.64% |
| March 31, 2024 | 92.16% |
| February 29, 2024 | 90.94% |
| January 31, 2024 | 87.83% |
| December 31, 2023 | 84.09% |
| November 30, 2023 | 79.36% |
| October 31, 2023 | 79.36% |
| September 30, 2023 | 79.36% |
| August 31, 2023 | 79.36% |
| July 31, 2023 | 79.36% |
| June 30, 2023 | 79.36% |
| May 31, 2023 | 79.36% |
| April 30, 2023 | 79.36% |
| March 31, 2023 | 79.36% |
| February 28, 2023 | 79.36% |
| January 31, 2023 | 79.36% |
| December 31, 2022 | 79.36% |
| November 30, 2022 | 79.36% |
| October 31, 2022 | 79.36% |
| September 30, 2022 | 74.86% |
| August 31, 2022 | 74.86% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Austar Lifesciences Ltd. | -- |
| Agilent Technologies, Inc. | 43.19% |
| Bio-Rad Laboratories, Inc. | 73.77% |
| Bruker Corp. | 68.72% |
| Azenta, Inc. | 87.08% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -19.00 |
| Beta (5Y) | 0.0064 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 63.80% |
| Historical Sharpe Ratio (5Y) | -0.2968 |
| Historical Sortino (5Y) | -0.5284 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 29.78% |